There are 2137 resources available
1605P - Number of untimely deaths prevented with ALK-inhibitors in Brazilian patients with advanced non-small cell lung cancer with ALK driver mutations
Presenter: Rodrigo Pellegrini
Session: E-Poster Display
Resources:
Abstract
1606P - Developing a readiness assessment framework for radioligand therapy
Presenter: Emmanuelle Plucker
Session: E-Poster Display
Resources:
Abstract
1607P - The impact of absolute neutrophil count on clinical trial participation in the United States
Presenter: Bamidele Adesunloye
Session: E-Poster Display
Resources:
Abstract
1608P - Publication rate and characteristics of cancer clinical trials in India
Presenter: Vinay Mathew Thomas
Session: E-Poster Display
Resources:
Abstract
1609P - Cancer care in Croatia, comparison with surrounding countries: Can we do better?
Presenter: Renata Kelemenic-Drazin
Session: E-Poster Display
Resources:
Abstract
1610P - Undergraduate education in medical oncology lags behind in Greek universities
Presenter: Dimitrios Ragias
Session: E-Poster Display
Resources:
Abstract
1611P - Healthcare resource utilization (HCRU) and costs in patients (pts) with advanced cancer treated with immune checkpoint inhibitors (ICIs) who experienced select immune-related adverse events (irAEs)
Presenter: Saby George
Session: E-Poster Display
Resources:
Abstract
1612P - Real-world evidence data (RWED) of financial toxicity (FT) in cancer patients (pts) receiving immunotherapy drugs (IOT)
Presenter: Daniel Vorobiof
Session: E-Poster Display
Resources:
Abstract
1613P_PR - An estimate of the 2-year oncology workload generated by each new patient: A real-world study
Presenter: Silvio Ken Garattini
Session: E-Poster Display
Resources:
Abstract
1614P - LGBTQ+ cancer patients: Are UK oncologists being supported to develop essential knowledge, attitudes and behaviours to provide quality care?
Presenter: Alison Berner
Session: E-Poster Display
Resources:
Abstract